ClearPoint Neuro amends director compensation plan; sets retainers and equity grants

ClearPoint Neuro, Inc.

Board chair annual retainer set at $75,000; other members receive $40,000.
Audit committee chair retainer $20,000; members $10,000; compensation and governance chairs $15,000 and $12,000 respectively.
New directors receive restricted stock award valued at $90,000 plus options for 2/3 of RSU shares.
Annual equity grants: each non-employee director gets $90,000 in RSUs plus options (2/3 of RSU count).
Options vest on first anniversary or day before next annual meeting; exercise price at fair market value on grant date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.